PIN42 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients- A Post-Hoc Analysis of Il-28B Subgroup

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1318
https://www.valueinhealthjournal.com/article/S1098-3015(12)01383-6/fulltext
Title : PIN42 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients- A Post-Hoc Analysis of Il-28B Subgroup
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01383-6&doi=10.1016/j.jval.2012.03.1318
First page : A244
Section Title : Infection
Open access? : No
Section Order : 846
Categories :
Tags :
Regions :
ViH Article Tags :